Pasar al contenido principal

APROXIMACION SINERGICA AL DESARROLLO DE TERAPIAS PARA TUMORES METASTASICOS Y DESORDENES NEURODEGENERATICOS USITILIZANDO CONJUGADOS POLIPEPTIDICOS VERSATILES

PID2019-108806RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIÓN DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRÍNCIPE FELIPE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A rationally designed self-immolative linker enhances the synergism between a polymer-rock inhibitor conjugate and neural progenitor cells in the treatment of spinal cord injury

  • Giraldo, Esther|||0000-0001-5488-3011
  • Nebot, V. J.
  • Dordevic, S.
  • Requejo-Aguilar, R.
  • Alastrue-Agudo, A.
  • Zagorodko, O.
  • Armiñán, A.
  • Martinez-Rojas, B.
  • Vicent, M.J.
  • Moreno Manzano, V.
[EN] Rho/ROCK signaling induced after spinal cord injury (SCI) contributes to secondary damage by promoting apoptosis, inflammation, and axon growth inhibition. The specific Rho-kinase inhibitor fasudil can contribute to functional regeneration after SCI, although inherent low stability has hampered its use. To improve the therapeutic potential of fasudil, we now describe a family of rationally-designed bioresponsive polymer-fasudil conjugates based on an understanding of the conditions after SCI, such as low pH, enhanced expression of specific proteases, and a reductive environment. Fasudil conjugated to poly-l-glutamate via a self-immolative redox-sensitive linker (PGA-SS-F) displays optimal release kinetics and, consequently, treatment with PGA-SS-F significantly induces neurite elongation and axon growth in dorsal root ganglia explants, spinal cord organotypic cultures, and neural precursor cells (NPCs). The intrathecal administration of PGA-SS-F after SCI in a rat model prevents early apoptosis and induces the expression of axonal growth- and neuroplasticity-associated markers to a higher extent than the free form of fasudil. Moreover, a combination treatment comprising the acute transplantation of NPCs pre-treated with PGA-SS-F leads to enhanced cell engraftment and reduced cyst formation after SCI. In chronic SCI, combinatory treatment increases the preservation of neuronal fibers. Overall, this synergistic combinatorial strategy may represent a potentially efficient clinical approach to SCI treatment., This research was funded by FEDER/Ministerio de Ciencia e Innovacion -Agencia Estatal de Investigacion [RTI2018-095872-B-C21/ERDF], Ministerio de Ciencia e Innovacion [SAF2016-80427-R, PID2019-108806RB-I00], Fundacio Marato TV3 [20172230, 20172231 and 20172110] Fundacion Step by Step, Agencia Valenciana de Innovacion (AVI) [INNVAL10/19/047] and MINECO/FEDER, UE; Fondo Europeo de Desarrollo Regional (FEDER) incluido en el Programa Operativo FEDER de la Comunidad Valenciana 2014-2020.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes

  • Andreu, Zoraida
  • Hidalgo, Marta R.
  • Masia, Esther
  • Romera-Giner, Sergio
  • Malmierca-Merlo, Pablo
  • López-Guerrero, José A.
  • García-García, Francisco
  • Vicent, María J.
[EN] Identifying novel breast cancer biomarkers will improve patient stratification, enhance therapeutic outcomes, and help develop non-invasive diagnostics. We compared the proteomic profiles of whole-cell and exosomal samples of representative breast cancer cell subtypes to evaluate the potential of extracellular vesicles as non-invasive disease biomarkers in liquid biopsies. Overall, differentially-expressed proteins in whole-cell and exosome samples (which included markers for invasion, metastasis, angiogenesis, and drug resistance) effectively discriminated subtypes; furthermore, our results confirmed that the proteomic profile of exosomes reflects breast cancer cell-of-origin, which underscores their potential as disease biomarkers. Our study will contribute to identifying biomarkers that support breast cancer patient stratification and developing novel therapeutic strategies. We include an open, interactive web tool to explore the data as a molecular resource that can explain the role of these protein signatures in breast cancer classification., This study was supported by the European Research Council (grant ERC-CoG-2014-648831 MyNano ) and the H2020 EU-OpenScreen-Drive project (grant agreement No. 823893). Our screening platform is part of the European Infrastructure, ERIC EUOpenScreen, and the Excellence Network, TeNTaCLES (Translational NeTwork for the CLinical application of Extracellular Vesicle-Tentacles-RED2018-102411-T). This research was also supported by the Spanish Ministry of Science and Innovation (PID2019-108806RBI00; PID2020-117211GB-I00; PID2021-124430OA-I00 funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and by FEDER, UE; and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, IMP/00019), co-funded by ERDF and CIBERONC (project n. CB22/12/00048). The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia, which belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001. Agreement 2019 between IVO and the Association Mou-te per elles.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulation of mitochondria–endoplasmic reticulum contacts (MERCs) by small molecules as a new strategy for restoring lipid metabolism in an amyotrophic lateral sclerosis model

  • Etxebeste-Mitxeltorena, Mikel
  • Flores-Romero, Héctor
  • Ramos-Inza, Sara
  • Masiá, Esther
  • Nenchova, Maria
  • Montesinos, Jorge
  • Martínez-González, Loreto
  • Porras, Gracia
  • Orzáez, Mar
  • Vicent, María J.
  • Gil, Carmen
  • Area-Gomez, Estela
  • García-Sáez, Ana J.
  • Martínez Gil, Ana
16 p.-15 fig.-3 tab.1 graph. abst., Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease without effective treatment. The progressive motoneuron death in ALS is associated with alterations in lipid metabolism. As its regulation occurs in mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs), modulation of mitochondria-ER contacts (MERCs) is emerging as a crucial factor in MAM formation and lipid metabolism control. Using the MERLIN biosensor in a high-throughput screening within the EU-OPENSCREEN ERIC, we discovered small molecules that increase MERCs in HCT116 cells, enhancing their ability to uptake cholesterol. We demonstrated that cholesterol trafficking is decreased in an ALS patient-derived cell model, and this trafficking is restored after treatment with the discovered MERC modulator 24. Electron microscopy revealed that treatment with compound 24 increases MERCs, promotes lipid droplet formation, and restores mitochondrial cristae. Overall, the brain-permeable MERC modulator, compound 24, may serve as a valuable pharmacological tool for studying MAM function and holds potential for in vivo studies in ALS and other MAM dysfunction diseases., This research was funded by European Commission Horizon 2020 Framework Programme (Project EU-OPENSCREEN-DRIVE - GA 823893), La Caixa and Luzón Foundation (grant no. HR21-00931), Luzón Foundation (UNZUE project), MCIN/AEI/10.13039/501100011033 (grant no. PID2019-105600RB-I00 to A.M., PID2019-108806RB-I00 to M.J.V., PID2020-115048RB-I00 to M.O., and PID2022-141616OA-I00 to H.F.-R.), Consejo Superior de Investigaciones Cientificas PTI+ Neuroaging (European Union Next Generation EU/PRTR), Spanish Health Institute Carlos III (grant no. CB18/05/00040 to A.M., and CB22/12/00048 to M.J.V.), and Deutsche Forschungsgemeinschaft. (grant CRC1403 to A.-J.G.-S. and CRC1218 advanced postdoctoral grant to H.F.-R.). Finally, A.-J.G.-S. thanks to the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 817758); and H.F.-R. acknowledges support by the Ikerbasque Basque Foundation for Science, COFUND, H2020-MSCA-COFUND-2020-101034228-WOLFRAM2, and by ERDF a way of making Europe (ERDF/EU)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A rationally designed polypeptide-based hybrid platform for targeted intranasal brain drug delivery

  • Conejos-Sánchez, Inmaculada
  • Sebastián, Víctor
  • Vicent, María J.
I. Conejos-Sánchez et al., Data will be made available on request., Intranasal administration represents a safe and non-invasive route for drug delivery to the brain; however, clinical translation remains limited due to anatomical and physiological barriers. We present a modular hybrid biomaterial platform (NanoInBrain) that bypasses the blood-brain barrier via the olfactory route and enables central nervous system (CNS) drug delivery. The platform integrates a rationally designed polypeptide-based nanocarrier with a depot-forming hydrogel vehicle - a hyaluronic acid-poly-L-glutamate crosspolymer (HA-CP, Yalic®) - adapted from dermatological applications to enhance nasal mucosal retention and brain uptake. We engineered the nanocarrier system using star-shaped poly-L-glutamate (StPGA) architectures and systematically tuned physicochemical properties to optimize mucosal interaction and CNS diffusion. We introduced mucoadhesive and mucodiffusive functionalities via C-terminal odorranalectin (OL) conjugation, which improved nasal epithelium permeation through receptor-mediated mechanisms. Redox-responsive disulfide crosslinking (StPGA-CL-SS) further enhanced mucosal transport by enabling thiol-mediated anchoring to mucin glycoproteins, outperforming inert click-crosslinked variants. Ex vivo Franz diffusion studies and a nasal-mucosa-on-chip model demonstrated robust permeation, with in vivo imaging confirming brain distribution and intracellular uptake in neurons and microglia. Incorporation of HA-CP prolonged nasal residence (∼4 h) and increased total brain accumulation while being well-tolerated. This new platform combines architectural tunability, bioresponsive surface chemistry, and depot-mediated delivery in a scalable, biocompatible nose-to-brain delivery system with potential for treating neurological disorders., This work was supported by the European Research Council (grant ERC-CoG-2014-648831 ″MyNano” and ERC-PoC- 2022-POC1 ″POLYBRAINT”) to M.J.V.); Health Foundation La Caixa Research Project NanoGBA (HR22-00602) and Caixa Impulse NanoERT (CI24-20222); the Spanish Ministry of Science, Innovation, and Universities (SAF2016-80427-R, PID2019-108806RB-I00 to M.J.V.; RTC-2017-6465-1, C.F-L Grant PTQ2018-010251 and D.M − B, Grant Industrial PhD DI-14-06926); the MINECO/FEDER, UE; European Regional Development Fund (ERDF) included in the ERDF operational program of Comunidad Valenciana 2014-2020; the Valencian Council for Education, Culture, University and Employment (CIPROM/2023/053) to J.M.G-V and V.H-P; the Valencian Innovation Agency (AVI) (L.T-C INNTAL31/19/005) and the Generalitat Valenciana (I.D-P, Grant VALi+d ACIF-2016-021 and BEFPI/2018/055). I.C-S. is funded by AEEC Junior Grant (Ref INVES211323CONE), and L.I.T.-S. has a predoctoral contract by the Valencian Council for Education, Universities and Employment (ACIF2021/420). VS acknowledges funding from project PID2024-160339OB-I00, PID2021-127847OB-I00, ‘Severo Ochoa’ Programme for Centres of Excellence in R&D of the Spanish Ministry of Science, Innovation and Universities (MICIU CEX2023-001286-S MICIU/AEI /10.13039/501100011033)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed